Skip to main content

Table 3 Percentage of samples showing CD68, CD163, and S100 expression in thymoma and thymic carcinoma

From: Difference in distribution profiles between CD163+ tumor-associated macrophages and S100+ dendritic cells in thymic epithelial tumors

  

Low

High

p-value

(a) CD 68

Thymoma

37

16

0.904

(A/AB/B1/B2/B3)

(0/11/12/12/2)

(3/3/5/2/3)

 

thymic carcinoma

9

7

 

(b) CD 163

Thymoma

19

34

0.024

(A/AB/B1/B2/B3)

(1/2/11/4/1)

(2/12/6/10/4)

 

thymic carcinoma

1

15

 

(c) S100

Thymoma

30

23

0.021

(A/AB/B1/B2/B3)

(2/10/12/5/1)

(1/4/5/9/4)

 

thymic carcinoma

14

2

 
  1. The median percentages of marker-positive TAMs or DCs in normal thymic samples, (1.31% for CD68, 7.28% for CD163, and 1.50% for S100), were used as the cut-off points to categorize the samples into the group with a low percentage of marker-positive TAMs or DCs ant that with high percentage of these cells.
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us